Tox21_300583

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 14 USDMF, 1 CEP/COS, 2 EU WC, 4 NDC API, 1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

99 FDF Dossiers, 47 FDA Orange Book, 18 Europe, 21 South Africa, 13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 13 SPI Pharma, 9 DKSH, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 2 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 4 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 12 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 13 Microlex e.U, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 15 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 27 Direct Compression, 24 Thickeners and Stabilizers, 16 Taste Masking, 15 Disintegrants & Superdisintegrants, 15 Granulation, 14 Coating Systems & Additives, 13 Co-Processed Excipients, 13 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 8 Empty Capsules, 6 Film Formers & Plasticizers, 6 Controlled & Modified Release, 6 Parenteral, 5 Solubilizers, 4 Topical, 4 Rheology Modifiers, 3 Coloring Agents, 2 Emulsifying Agents, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 Finished Drug Prices

9 Finished Drug Prices

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

9 Health Canada Patents

9 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

5 FDA-approved antivirals could target COVID-19: study

02 Jul 2020

// A. Weintraub FIERCE BIOTECH

Farma Glow Receives FDA Warning Letter

24 Oct 2018

// FDA

List Of Drugs Approved By Anvisa

03 Oct 2016

// ANVISA

Digital Content for Tox21_300583

Tox21_300583

Tox21_300583

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers

14 USDMF

1 CEP/COS

2 EU WC

4 NDC API

1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

99 FDF Dossiers

47 FDA Orange Book

18 Europe

21 South Africa

13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SOLUTION;ORAL - 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc

13 SPI Pharma

9 DKSH

7 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

2 Actylis

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 BASF

4 DFE Pharma

1 Finar

4 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

12 Kerry

1 Kima Chemical

3 Lonza Capsugel

13 Microlex e.U

2 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

1 Qualicaps

15 Roquette

1 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

1 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders

27 Direct Compression

24 Thickeners and Stabilizers

16 Taste Masking

15 Disintegrants & Superdisintegrants

15 Granulation

14 Coating Systems & Additives

13 Co-Processed Excipients

13 Lubricants & Glidants

11 Chewable & Orodispersible Aids

8 Empty Capsules

6 Film Formers & Plasticizers

6 Controlled & Modified Release

6 Parenteral

5 Solubilizers

4 Topical

4 Rheology Modifiers

3 Coloring Agents

2 Emulsifying Agents

1 API Stability Enhancers

1 Surfactant & Foaming Agents

CAPSULE;ORAL - 15MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 20MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 30MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - 40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

FOR SOLUTION;ORAL - 1MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons